Intervention Review

Galantamine for Alzheimer's disease and mild cognitive impairment

  1. Clement Loy1,*,
  2. Lon Schneider2

Editorial Group: Cochrane Dementia and Cognitive Improvement Group

Published Online: 25 JAN 2006

Assessed as up-to-date: 15 NOV 2005

DOI: 10.1002/14651858.CD001747.pub3


How to Cite

Loy C, Schneider L. Galantamine for Alzheimer's disease and mild cognitive impairment. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD001747. DOI: 10.1002/14651858.CD001747.pub3.

Author Information

  1. 1

    Garvan Institute of Medical Research, Level 7, Darlinghurst, NSW, Australia

  2. 2

    University of Southern California Keck School of Medicine, Los Angeles, CA, USA

*Clement Loy, Level 7, Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, NSW, 2010, Australia. clementloy@fastmail.fm.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 25 JAN 2006

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.